FNDC5 and metabolic syndrome: In obese people, higher irisin levels may be the result of greater irisin production in the more developed adipose and muscle tissue or may reflect a compensatory increase in irisin levels to combat obesity and metabolic syndrome to overcome irisin resistance, just as elevated insulin and leptin levels occur in patients with insulin and leptin resistance.